Schmid Timothy: insider trades.
Schmid Timothy reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($9.2M), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Schmid Timothy
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Johnson & Johnson (JNJ) | Officer · EVP, WW Chair, MedTech | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-02 | Johnson & Johnson | S | 22,527 | $274.74 | 25,447 | Form 4 |
| 2026-09-02 | Johnson & Johnson | S | 11,070 | $274.74 | 25,447 | Form 4 |
| 2026-09-02 | Johnson & Johnson | M | 11,070 | $131.94 | 36,517 | Form 4 |
| 2026-09-02 | Johnson & Johnson | M | 22,527 | $151.41 | 47,974 | Form 4 |
Questions
What stock did Schmid Timothy buy or sell?
Schmid Timothy reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($9.2M), across 1 company.
Is Schmid Timothy the same person as other filers with this name?
This page covers SEC CIK 1998491 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/schmid-timothy-1998491.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.